Search Results
9 items found for "Thomas Huber"
- Developing a PROTAC to Degrade the Constitutively Active Onco-GPCR in Uveal Melanoma
Thomas Sakmar’s laboratory at Rockefeller University, where she studies the signaling and degradation started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined the lab of Thomas
- GPCR Retreat 2023 - Part II
Thomas Sakmar’s laboratory at The Rockefeller University, where she study’s the signaling and degradation started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined the lab of Thomas
- Ep 56 with Dr. Adriano Marchese
He then moved to Thomas Jefferson University in Philadelphia, PA, for his postdoctoral training in Jeff
- Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19
Schinke , Nadja Käding , Jens Y Humrich , Otávio Cabral-Marques , Joana P Bernardes , Neha Mishra , Thomas
- Ep 18 with Dr. Yamina Berchiche
Oprea , Thomas Sakmar , Aurelien Rizk & Yaroslav Nikolaev .
- The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure
Meghana S Pagadala , Lauren M Clubb , Joshua Chiou , Sanju Sinha , Marin Matic , Francesco Raimondi , Thomas
- Ep 42 with Dr. Randy Hall
to the Vollum Institute in Portland, Oregon, to do a post-doctoral fellowship in the laboratory of Thomas
- Ep 66 with Dr. Antony A. Boucard Jr
Thomas Südhof .
- Session IV | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
I initially worked on mTOR in the pathogenesis of Tuberous Sclerosis Complex and then moved to the Francis